Contributor Page
Arnold & Porter Kaye Scholer LLP
 
Email  |  Website  |  Articles
Contact Details
Tel: +1 202 942.5000
Fax: +1 202 942.5999
601 Mass. Ave., NW
Washington, DC
DC 20001-3743
United States
By Jacqueline Mulryne
The European Commission has finally published the draft amendment to Regulation No 847/2000 regarding the concept of "similar medicinal product" for the purposes of the Orphan Medicinal Products Regulation.
By C. Scott Lent, Matthew Tabas, Matthew H. Fine
The FTC's stated purpose for its workshop was to study the barriers to generic drug competition and whether other market forces create inefficiencies that lead to higher drug prices.
By Michael Weigel
The German Bar Association's bimonthly magazine, BRAK-Mitteilungen, published Litigation partner Dr. Michael Weigel's article discussing model lawsuits for the declaration of claims.
By Nicolas Dumont
Auch die 67. IAA hat es wieder gezeigt: Neben der Elektrifizierung zählt die Entwicklung automatisierter Fahrzeuge zu den wichtigsten Trends der Automobilindustrie.
By Edward Bintz, Jeffrey L. London, Douglas Pelley, Kathleen Wechter
The tax reform proposals under consideration in both houses of Congress threaten to upend longstanding executive compensation practices.
By John Barker, John Bellinger, III, Ronald K. Henry, Soo-Mi Rhee, Baruch Weiss, Nicholas Townsend, Tal R. Machnes
On November 8, 2017, the Trump administration followed through on its promise to reverse course on the loosening of US sanctions involving Cuba in recent years, in pursuit of its stated policy to ...
By Libby Amos
In July, we reported that the European Medicines Agency and the US Food and Drug Administration had announced a joint proposal to promote the use of innovative approaches to paediatric drug development.
By Frank Liss, Yasmine Harik
Cartel regulation involves the enforcement of antitrust laws that prohibit horizontal agreements between competitors to fix prices, manipulate bidding processes and otherwise divide the market, ...
By Kenneth Chernof, John D. Lombardo, Daphne Morduchowitz, Mark Sokolow, David J. Weiner, Paul Beavers, Tiffany Ikeda, Michael Kientzle, Colleen Lima, Willow White Noonan
The Federal Circuit affirmed the ITC's decision without explanation.
By Kenneth Chernof, John D. Lombardo, Daphne Morduchowitz, Andrew K. Solow, David J. Weiner, Paul Beavers, Tiffany Ikeda, Michael Kientzle, Colleen Lima, Willow White Noonan
Notably, the defendant did not dispute the authenticity of the plaintiffs' screenshots.
By Kenneth Chernof, John D. Lombardo, Daphne Morduchowitz, Andrew K. Solow, David J. Weiner, Paul Beavers, Tiffany Ikeda, Michael Kientzle, Colleen Lima, Willow White Noonan
The Court of Appeal accordingly remanded the case to the trial court to determine the measure of damages to which the plaintiff class was entitled.
By David Freeman, Jr., Christopher Allen, Kenneth Chernof, Michael Mancusi, Michael Mierzewski, Gilbert Serota, Robert Fischbeck, Helen Mayer Clark, Kevin Toomey
The resolution will preclude the CFPB from promulgating a new rule that is substantially the same as the Final Rule without Congress's specific authorization.
By Bonnie Clemence, Jacqueline Mulryne, Lincoln Tsang, Ian Dodds-Smith
The Judge Rapporter asked why it was not sufficient that the MA and assessment report can be challenged in the RMS.
By Jacqueline Mulryne
Last week, the European Commission published its ten-year report on the implementation of the Paediatric Regulation 1901/2006 (together with a useful Questions & Answers document).
By Alan Rothman
The following recent developments at the Judicial Panel on Multidistrict Litigation provide some practical pointers when facing litigation in multiple jurisdictions.
Contributor's Topics
More...